These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis in progressive crescentic glomerulonephritis. Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789 [TBL] [Abstract][Full Text] [Related]
9. Complement-mediated killing of mesangial cells in experimental glomerulonephritis: cell death by a combination of apoptosis and necrosis. Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Ohashi R; Sugisaki Y; Yamanaka N Nephron; 2000 Oct; 86(2):152-60. PubMed ID: 11014985 [TBL] [Abstract][Full Text] [Related]
14. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis. Bessho K; Mizuno S; Matsumoto K; Nakamura T Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276 [TBL] [Abstract][Full Text] [Related]
15. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo. Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272 [TBL] [Abstract][Full Text] [Related]